Literature DB >> 2791307

ELISA for measuring porphobilinogen deaminase in human erythrocytes.

L Lannfelt1, L Wetterberg, L Lilius, S Thunell, P Gellerfors.   

Abstract

An ELISA method has been developed to quantitate human porphobilinogen deaminase in erythrocyte lysate. The antiserum used in the assay was raised against the erythropoietic form of human porphobilinogen deaminase. The IgG fraction was characterized by use of immunoblotting technique, rocket immunoelectrophoresis and immunotitration and shown to be monospecific. The measuring range of the method was from 4 ng to 50 pg. Intra- and inter-assay coefficients of variation were 6% and 7%, respectively. Erythrocyte lysates from 97 apparently healthy individuals were assayed giving a mean erythrocyte porphobilinogen deaminase protein concentration of 150 +/- 28 SD (micrograms/g Hb) and a specific enzyme activity of 750 +/- 140 SD (nkat/g). Eight patients with acute intermittent porphyria were also investigated. A decreased concentration of enzyme protein, i.e. 84 +/- 13 SD (micrograms/g Hb) with a normal specific activity, was found.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791307     DOI: 10.1016/0009-8981(89)90338-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Genetic heterogeneity of the porphobilinogen deaminase gene in Swedish families with acute intermittent porphyria.

Authors:  J S Lee; G Lundin; L Lannfelt; L Forsell; C Picat; B Grandchamp; M Anvret
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  Heteroduplex analysis detects frameshift and point mutations in patients with acute intermittent porphyria.

Authors:  W E Schreiber; F Fong; B A Nassar; A Jamani
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

3.  delta-Aminolevulinic acid effects on neuronal and glial tumor cell lines.

Authors:  L Helson; S Braverman; J Mangiardi
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

4.  Frameshift mutations in exons 9 and 10 of the porphobilinogen deaminase gene produce a crossreacting immunological material (CRIM)-negative form of acute intermittent porphyria.

Authors:  W E Schreiber; F Fong; A Jamani
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.